Prostate cancer

What Is Prostate Cancer?

Prostate cancer develops within the prostate gland, a small organ located below the bladder in men that produces fluid contributing to semen.

The incidence of prostate cancer varies considerably by geographic location and ethnic background, with the highest incidence rates observed among African American and French West Indian populations, exceeding one hundred seventy new cases per one hundred thousand people.¹

Interestingly, Asian men living in the United States have substantially higher prostate cancer rates than their counterparts living in native countries, and incidence in previously low risk Asian countries has increased alongside rising affluence.¹

Age, ethnicity, and family history of prostate cancer are well established risk factors, alongside geography and genetic factors.
National Center for Biotechnology Information

Symptoms

Early prostate cancer often produces no noticeable symptoms, which is one reason screening plays such an important role in detecting the disease before it advances.

When symptoms do occur, they can include difficulty urinating, weak or interrupted urine flow, blood in the urine or semen, and discomfort in the pelvic area.

More advanced disease can cause bone pain, particularly in the hips, back, or pelvis, reflecting potential spread of cancer beyond the prostate gland itself.

Causes

Prostate cancer develops when cells within the prostate gland accumulate genetic changes that allow them to grow and divide in an uncontrolled manner.

Family history represents a major risk factor, and having a brother or father diagnosed with prostate cancer increases an individual’s own risk, with that risk being inversely related to the age at which the relative was diagnosed.¹

Risk is particularly elevated when a first degree relative was diagnosed with prostate cancer before age sixty five, and interestingly, a family history of breast cancer is also associated with increased prostate cancer risk.²

Risk Factors

Age, ethnicity, and family history of prostate cancer are the most well established risk factors, alongside additional contributing factors including geography and inherited genetic variation.¹

Environmental factors, including dietary patterns and other lifestyle related factors, also contribute meaningfully to overall prostate cancer risk.¹

Because risk varies so considerably by population and geography, understanding an individual’s specific risk profile can help guide personalized screening recommendations and timing.¹

Complications

The widespread use of prostate specific antigen screening has led to a nearly seventy percent increase in newly diagnosed prostate cancer cases, most of which are classified as low risk disease detected at an early stage.³

However, this same screening approach has also led to meaningful overdiagnosis and subsequent overtreatment, referring to detection of latent disease that likely would never have caused symptoms or harm during the patient’s lifetime.³

The Gleason score, a grading system based on how cancer cells appear under a microscope, plays a central role in distinguishing lower risk disease from more aggressive cancer requiring immediate treatment.⁴

Treatment

Active surveillance has become an important conservative management approach for patients with low risk or favorable risk disease, avoiding the long term quality of life effects associated with immediate aggressive treatment.⁴

This approach involves close monitoring through regular digital rectal examination, periodic biopsy, and serial prostate specific antigen testing, with eligible patients typically having a Gleason score of six or select cases of Gleason three plus four disease.⁴

Long term outcomes for active surveillance have demonstrated its safety, with cancer specific mortality rates of only about three percent at ten to fifteen years of follow up among appropriately selected patients.⁴

Prevention

Because prostate cancer results from a complex combination of genetic, hormonal, and environmental factors, there is no guaranteed way to prevent the disease entirely.

Maintaining a healthy diet and lifestyle may offer some modest benefit in reducing overall risk, though the evidence for specific dietary interventions remains an active area of research.¹

For men with significant family history, discussing personalized screening timing with a healthcare provider supports earlier detection while balancing the risks of overdiagnosis associated with widespread screening.³

Why Visual Communication Matters for Prostate Cancer

Explaining the difference between low risk disease suitable for active surveillance and more aggressive cancer requiring treatment requires visuals that make risk stratification concepts clear to patients facing difficult decisions.

Pharmaceutical companies, urology practices, and patient education organizations rely on precise illustration and animation to explain prostate cancer diagnosis and treatment options.

• Illustrating prostate anatomy and tumor location within the gland
• Animating the Gleason grading system and risk stratification process
• Explaining active surveillance protocols and monitoring schedules
• Visualizing prostate specific antigen testing and its role in screening
• Supporting patient education on treatment decision making
• Creating training materials for urology and oncology clinicians

How Biotic Artlab Supports Prostate Cancer Communication

We work with pharmaceutical companies, urology practices, and healthcare organizations to create scientifically accurate visuals that make prostate cancer easier to understand.

• Custom 3D animations of prostate anatomy and tumor development
• Detailed illustrations of Gleason grading and risk stratification
• Visualizations of active surveillance monitoring protocols
• Patient facing materials on screening and treatment decision support
• Clinical training content for urology and oncology teams
• Conference presentations and marketing visuals for urologic oncology audiences

Frequently Asked Questions

What are common risk factors for prostate cancer?

Age, ethnicity, family history, and geography are the most well established risk factors.¹

Does family history matter for prostate cancer risk?

Yes, having a father or brother diagnosed with prostate cancer, particularly before age sixty five, meaningfully increases individual risk.²

What is active surveillance?

It is a conservative management approach involving close monitoring rather than immediate treatment, appropriate for select low risk patients.⁴

What is the Gleason score?

It is a grading system based on how cancer cells appear under a microscope, used to help distinguish lower risk from more aggressive disease.⁴

Does PSA screening always benefit patients?

Not always. While it increases early detection, it has also led to meaningful overdiagnosis and overtreatment of disease that may never have caused harm.³

Can prostate cancer be prevented?

There is no guaranteed prevention method, though healthy lifestyle choices and personalized screening may help reduce risk and support earlier detection.¹

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to prostate cancer, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. Addressing the Contribution of Previously Described Genetic and Epidemiological Risk Factors Associated With Increased Prostate Cancer Risk.
2. National Center for Biotechnology Information. First Degree Family History of Breast Cancer Is Associated With Prostate Cancer Risk.
3. National Center for Biotechnology Information. Active Surveillance in Intermediate Risk Prostate Cancer, Is It Safe.
4. National Center for Biotechnology Information. Active Surveillance for the Management of Localized Prostate Cancer, Guideline Recommendations.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, or individualized advice from a qualified healthcare professional.